Moxifloxacin Hcl Powder
NDC Package 48943-0041-2
Package Information
Moxifloxacin Hcl powders is a medication a quinolone antibiotic used for eye infections. This formulation utilizes a powder delivery system. Marketed by Chongqing Huapont Shengchem Pharmaceutical Co., Ltd., this product is identified by NDC 48943-0041.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 48943 - Chongqing Huapont Shengchem Pharmaceutical Co., Ltd.
- 48943-0041 -
- 48943-0041-2 - 5 kg in 1 BAG
- 48943-0041 -
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (48943-0041). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 48943-0041-2 identifies a specific commercial package of 5 kg in 1 bag of Moxifloxacin Hcl (UNFINISHED drug), a bulk ingredient labeled by Chongqing Huapont Shengchem Pharmaceutical Co., Ltd.. This powder is formulated for use and contains moxifloxacin hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Chongqing Huapont Shengchem Pharmaceutical Co., Ltd. on December 01, 2025. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
This medication is a quinolone antibiotic used for eye infections.
How is this Chongqing Huapont Shengchem Pharmaceutical Co., Ltd. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 48943004102. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.